GALLO, Antonio
 Distribuzione geografica
Continente #
EU - Europa 3.125
NA - Nord America 2.288
AS - Asia 326
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 5.746
Nazione #
US - Stati Uniti d'America 2.282
IE - Irlanda 1.017
IT - Italia 769
GB - Regno Unito 340
UA - Ucraina 275
CN - Cina 209
DE - Germania 209
SE - Svezia 125
AT - Austria 104
TR - Turchia 91
FR - Francia 83
FI - Finlandia 71
GR - Grecia 69
BE - Belgio 22
NL - Olanda 14
CA - Canada 6
JP - Giappone 6
RU - Federazione Russa 6
VN - Vietnam 6
ES - Italia 5
IR - Iran 5
CH - Svizzera 3
EU - Europa 3
IN - India 3
HR - Croazia 2
IL - Israele 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
KR - Corea 1
MK - Macedonia 1
PK - Pakistan 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.746
Città #
Dublin 1.015
Jacksonville 448
Chandler 390
Princeton 131
Ann Arbor 113
Caserta 111
Roxbury 107
Vienna 104
Medford 94
New York 88
Beijing 65
Bremen 64
Wilmington 60
Woodbridge 56
Boardman 47
Norwalk 42
Cambridge 41
Nanjing 41
San Mateo 40
Naples 39
Rome 37
Napoli 32
Des Moines 26
Brussels 22
London 21
Milan 19
Jinan 18
Mountain View 15
Shenyang 15
Ashburn 12
Houston 11
Redwood City 11
Auburn Hills 10
Turin 10
Düsseldorf 8
Falls Church 8
Genoa 8
Fairfield 7
Kunming 7
Lanzhou 7
Munich 7
Sala Consilina 7
Cercola 6
Dong Ket 6
Haikou 6
Nanchang 6
Santa Maria Capua Vetere 6
Verona 6
Bologna 5
Groningen 5
Guangzhou 5
Hebei 5
Tokyo 5
Aversa 4
Busto Arsizio 4
Gorgonzola 4
Gunzenhausen 4
Lappeenranta 4
Padova 4
Salerno 4
Shanghai 4
Taiyuan 4
Taizhou 4
Tianjin 4
Bacoli 3
Bedford 3
Boydton 3
Brescia 3
Buffalo 3
Buscate 3
Livorno 3
Luzzano 3
Ningbo 3
Nürnberg 3
Palermo 3
Parabiago 3
San Vito di Cadore 3
Tappahannock 3
Toronto 3
Trecase 3
Treviso 3
Turi 3
Varedo 3
Washington 3
Zhengzhou 3
Afragola 2
Amsterdam 2
Capua 2
Casoria 2
Castelcovati 2
Cava Dei Tirreni 2
Cefalù 2
Cervignano del Friuli 2
Chions 2
Copertino 2
Dearborn 2
Falconara Marittima 2
Fisciano 2
Florence 2
Giugliano In Campania 2
Totale 3.612
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 432
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 100
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 99
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 97
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 95
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 94
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 88
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 86
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 85
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 79
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 79
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 76
Advantages of QBI in TBSS analyses. 76
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 74
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 73
The role of diet in multiple sclerosis: A review 73
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 68
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 68
Quality of life in women with multiple sclerosis and overactive bladder syndrome 67
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 67
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 65
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 64
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 63
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 63
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 63
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 61
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 60
Proton spectroscopic imaging - Principles and clinical applications in neurology 59
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 59
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 58
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 58
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 58
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 57
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 57
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 56
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 56
Assessing response to interferon-β in a multicenter dataset of patients with MS 56
NEUROIMAGING NEI DISTURBI DELL’UMORE 55
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 55
Malattie del Sistema nervoso Autonomo 52
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 52
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 51
Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. 51
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 51
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 51
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 50
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 50
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 49
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 48
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 48
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 48
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 47
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 47
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 46
Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery. 45
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 44
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. 44
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 44
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 42
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 42
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 41
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 40
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 40
Functional plasticity of the visual system in multiple sclerosis. 40
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients 40
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 40
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 40
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 40
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 38
Relationship of Cortical Atrophy to Fatigue in Patients With Multiple Sclerosis 36
NEURORADIOLOGIA E SCLEROSI MULTIPLA 36
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 36
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals 36
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 36
Correlates of executive functions in multiple sclerosis based on structural and functional mr imaging: Insights from a multicenter study 35
Health-Related Coping and Social Interaction in People with Multiple Sclerosis Supported by a Social Network: Pilot Study With a New Methodological Approach 35
Two Unexpected Cases of Rosacea during Fingolimod Therapy 35
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 35
Impaired metabolic capacity in the perirhinal and posterior parietal cortex lead to dissociation between attentional, motivational and spatial components of exploration in the Naples High-Excitability rat 34
Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS 33
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 33
The effect of IFN-beta on black holes in patients with multiple sclerosis 32
Multiple sclerosis patients and immunomodulation therapies: the potential role of new MRI techniques to assess responders versus non-responders 32
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region. 32
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 32
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 32
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 31
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 31
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 31
Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis 30
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 30
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS? 29
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 28
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 28
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 28
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 27
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 26
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 26
Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study 25
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 25
Totale 5.435
Categoria #
all - tutte 23.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.074


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 18 26
2019/2020664 110 134 23 13 79 23 107 12 86 29 23 25
2020/2021830 59 3 76 61 185 16 122 87 17 81 93 30
2021/2022970 53 19 23 37 293 27 25 42 60 66 72 253
2022/20231.805 182 22 34 128 172 133 7 87 955 26 26 33
2023/2024826 73 37 55 107 264 123 69 29 45 22 2 0
Totale 6.133